Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.61 |
| ▸ | ABAT | P80404 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.61 |
| ▸ | FDPS | P14324 | 1/20 | 0.58 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.51 |
| ▸ | PRKDC | P78527 | 1/20 | 0.50 |
| ▸ | ERN1 | O75460 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155784 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| SCHEMBL29723752 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| SCHEMBL30882827 | 0.83 | ALDH1A1 (0.73) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| SCHEMBL28988638 | 0.82 | XDH (0.66) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| SCHEMBL29130913 | 0.82 | TUBB1 (0.47) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL1330962 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL5308959 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL25202 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL29364994 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRTRIM24HPGDALDH5A1 | |
| SCHEMBL24925872 | 0.80 | FDPS (0.50) | ALDH1A1TSHRTRIM24HPGDALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116891471-A | Preparation method of non-neridrone bulk drug | 江苏德源药业股份有限公司 | 2023-10-17 | — | — | CN | claimed |
| EP-4565562-B1 | PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES | NXERA PHARMA UK LTD (GB) | 2026-05-27 | — | — | EP | disclosed |
| EP-4519384-B1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | PROMEGA CORP (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12583839-B2 | PD-L1 antagonist compound | ADLAI NORTYE BIOPHARMA CO., LTD. (CN) | 2026-03-24 | — | — | US | disclosed |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12559504-B2 | Benzotriazole derivative | UBE CORPORATION (JP) | 2026-02-24 | — | — | US | disclosed |
| US-20260042745-A1 | PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES | NXERA PHARMA UK LIMITED (GB) | 2026-02-12 | — | — | US | disclosed |
| CN-121449609-A | Preparation method of non-neridrone bulk drug | 江苏海洋大学 | 2026-02-03 | — | — | CN | disclosed |
| EP-4680336-A1 | AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | Ventus Therapeutics U.S., Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4676591-A2 | SMALL MOLECULE FSH RECEPTOR MODULATORS | Ferring B.V. (NL) | 2026-01-14 | — | — | EP | disclosed |
| US-20060116401-A1 | Antibacterial compounds | ASTRAZENECA AB (SE) | 2006-06-01 | — | — | US | disclosed |
| EP-1567521-A1 | ANTIBACTERIAL COMPOUNDS | AstraZeneca AB (SE) | 2005-08-31 | — | — | EP | disclosed |
| US-6849619-B2 | Substituted pyridoindoles as serotonin agonists and antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-02-01 | — | — | US | disclosed |
| US-20040186094-A1 | Substituted pyridoindoles as serotonin agonists and antagonists | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-09-23 | — | — | US | disclosed |
| WO-2004048370-A1 | ANTIBACTERIAL COMPOUNDS | ASTRAZENECA AB (SE) | 2004-06-10 | — | — | WO | disclosed |
| US-6699852-B2 | ANTISEROTONIN AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS; ANTIDEPRESSANTS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-02 | — | — | US | disclosed |
| EP-1343791-A2 | SUBSTITUTED TETRACYCLIC PYRIDOINDOLES AS SEROTONIN AGONISTS AND ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-09-17 | — | — | EP | disclosed |
| US-20020173503-A1 | Substituted pyridoindoles as serotonin agonists and antagonists | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-11-21 | — | — | US | disclosed |
| WO-2002059129-A2 | SUBSTITUTED TETRACYCLIC PYRIDOINDOLES AS SEROTONIN AGONISTS AND ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-08-01 | — | — | WO | disclosed |
| US-4024274-A | Benzylamine derivatives and process for preparing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559504-B2 | Benzotriazole derivative | KEAP1, NFE2L2, NCOR1 | ALDH1A1 198/4885TSHR 2245/4885TRIM24 1335/4885 |
| US-20020173503-A1 | Substituted pyridoindoles as serotonin agonists and antagonists | HTR1A, HTR1B, HTR7 | ALDH1A1 2258/4885TSHR 305/4885TRIM24 4387/4885 |
| US-20040186094-A1 | Substituted pyridoindoles as serotonin agonists and antagonists | HTR1A, HTR1B, HTR7 | ALDH1A1 2258/4885TSHR 305/4885TRIM24 4387/4885 |
| US-20060116401-A1 | Antibacterial compounds | MRPL21, NR0B2, CYP8B1 | ALDH1A1 927/4885TSHR 1360/4885TRIM24 4684/4885 |
| US-20260042745-A1 | PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES | PTGER4, PTGER1, PTGER2 | ALDH1A1 1803/4885TSHR 196/4885TRIM24 4626/4885 |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFH, CFB, C5 | ALDH1A1 3094/4885TSHR 204/4885TRIM24 4494/4885 |
| US-12583839-B2 | PD-L1 antagonist compound | CD274, PDCD1LG2, PDCD1 | ALDH1A1 747/4885TSHR 79/4885TRIM24 4686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.